1) Welte K, Zeidler C, Dale DC. Severe congenital neutropenia. Semin Hematol. 2006; 43: 189-95
|
|
|
2) Boxer LA, Newburger PE. A molecular classification of congenital neutropenia syndromes. Pediatric Blood & Cancer. DOI, 21 Jun, 2007
|
|
|
3) Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 2000; 96: 2317-22
|
|
|
4) Ancliff PJ, Gale RE, Michael J, et al. Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood. 2002; 100: 707-9
|
|
|
5) Kawaguchi H, Kobayashi M, Nakamura K, et al. Dysregulation of transcriptions in primary granule constituents during myeloid proliferation and differentiation in patients with severe congenital neutropenia. J Leuk Biol. 2003; 73: 225-34
|
|
|
6) Bellanne-Chantelot C, Clauin S, Leblanc T, et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood. 2004; 103: 4119-25
|
|
|
7) Horwitz MS, Duan Z, Korkmaz B, et al. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood. 2007; 109: 1817-24
|
|
|
8) Horwitz M, Benson KF, Person RE, et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet. 1999; 23: 433-6
|
|
|
9) Haddy TB, Rena SR, Castro O, et al. Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med. 1999; 133: 15-22
|
|
|
10) Benson KF, Li FQ, Person RE, et al. Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase. Nat Genet. 2003; 35: 90-6
|
|
|
11) Hunter MG, Drunhan LJ, Massullo PR, et al. Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cells surface expression of the granulocyte colony-stimulating factor receptor. Am J Hematol. 2003; 74: 149-55
|
|
|
12) El Ouriaghli F, Fujiwara H, Melenhorst JJ, et al. Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: Implications for the regulation of granulopoiesis. Blood. 2003; 101: 1752-8
|
|
|
13) Grenda DS, Murakami M, Ghatak J, et al. Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. Blood. 2007; doi: 10. 1182/blood-2006-11-057299
|
|
|
14) Kollner I, Sodeik B, Schreek S, et al. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood. 2006; 108: 493-500
|
|
|
15) Salipante S, Benson KF, Luty J, et al. Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia. Hum Mutat. 2007; DOI 10. 1002/humu. 20520
|
|
|
16) Skokowa J, Cario G, Uenalan M, et al. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat Med. 2006; 12: 1191-7
|
|
|
17) Massullo P, Druhan LJ, Bunnell BA, et al. Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes. Blood. 2005; 105: 3397-404
|
|
|
18) Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2007; 39: 86-92
|
|
|
19) Cilenti L, Soundarapandian MM, Kyriazis GA, et al. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J Biol Chem. 2004; 279: 50295-301
|
|
|
20) Matsubara K, Imai K, Okada S, et al. Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency. Haematologica (印刷中)
|
|
|
21) Carlsson G, Aprikyan AA, Tehranchi R, et al. Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood. 2004; 103: 3355-61
|
|
|
22) Karsunky H, Zeng H, Schmidt T, et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet. 2002; 30: 295-300
|
|
|
23) Person RE, Li FQ, Duan Z, et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet. 2003; 34: 308-12
|
|
|
24) Fontana S, Parolini S, Vermi W, et al. Innate immunity defects in Hermansky-Pudlak type 2 syndrome. Blood. 2006; 107: 4857-64
|
|
|
25) Jung J, Bohn G, Allroth A, et al. Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2. Blood. 2006; 108: 362-9
|
|
|
26) Hernandez PA, et al. Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet. 2003; 34: 70-6
|
|
|
27) Aprikyan AAG, Liles WC, Park JR, et al. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. Blood. 2000; 95: 320-7
|
|
|
28) Devriendt K, Kim AS, Mathijs G, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet. 2001; 27: 313-7
|
|
|
29) Ancliff PJ, Blundell MP, Cory GO, et al. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood. 2006; 108: 2182-9
|
|
|
30) Boocok GR, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet. 2003; 33: 97-101
|
|
|
31) Ganapahi KA, Austin KM, Lee C-S, et al. The human Shwachman-Diamond syndrome protein, SBDS, associates withs ribosomal RNA. Blood. DOI 2 May 2007
|
|
|
32) Flygare J, Aspesi A, Bailey JC, et al. Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood. 2007; 109: 980-6
|
|
|